Study links effects of withdrawal to compulsive drug use and craving
Finding could lead to new addiction therapiesThe study, led by Paul Kenny, Ph.D., an assistant professor at Scripps Research's campus in Jupiter, Florida, and Scott Chen, Ph.D., of the National Institutes of Health Animal Center, appears in the Wednesday, May 31 issue of the Journal of Neuroscience, the official journal of the Society for Neuroscience.
The research fills many gaps in our understanding of how the brain changes during drug addiction. While scientists had previously shown that drugs such as heroin stimulate the brain's pleasure centers and thereby motivate drug consumption, the role of withdrawal-associated inhibitory effects on brain pleasure centers in motivating drug intake had been more difficult to quantify.
"This is a missing piece of the puzzle that scientists have been interested in for many years," Kenny said. "Withdrawal was important anecdotally, but there had been no solid empirical data demonstrating an instrumental role of withdrawal in addiction-like behaviors."
Kenny and colleagues now provide strong evidence that withdrawal contributes to the development of compulsive drug consumption in addicts. During the study, rodents were permitted to self-administer various levels of heroin. Those receiving the highest levels showed withdrawal-like decreases in the activity of the brain's reward systems. Crucially, as this withdrawal effect got worse, their drug intake became greater.
"As levels of drug consumption increase, the withdrawal state becomes more profound," Kenny said. "Taking more of the drug alleviates withdrawal, but also makes the underlying condition worse. You set up a vicious cycle where you're taking more of the drug to relieve a progressively worsening withdrawal."
Importantly, the researchers also identified a previously unknown source of drug craving, provoked by stimuli linked to withdrawal through Pavlovian conditioning. In the study, cues in the environment-a buzzer and light-repeatedly paired with drug withdrawal by themselves came to precipitate a withdrawal-like state and to prompt drug seeking.
"Through classical conditioning, these cues alone could precipitate drug-seeking behaviors," said Kenny. "Thus, in addition to memories of the pleasurable effects of drugs, memories of aversive drug withdrawal may also drive drug craving and relapse."
This line of research has the potential to aid in the development of new therapies for addiction. "If we understand the underlying biology, we may be able to block it to eliminate craving and prevent relapse among drug addicts," Kenny said.
Other authors of the study, titled "Conditioned withdrawal drives heroin consumption and decreases brain reward sensitivity," include: Scott A. Chen, Laboratory of Clinical and Translational Studies, NIH Animal Center, Poolesville, MD; Osamu Kitamura, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan; and Athina Markou and George Koob, Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA.
The work was supported by the National Alliance for Research on Schizophrenia and Depression, National Institute of Drug Addiction (NIDA), and a NIDA National Research Service Award.
About The Scripps Research Institute
The Scripps Research Institute, headquartered in La Jolla, California, in 18 buildings on 40 acres overlooking the Pacific Ocean, is one of the world's largest independent, non-profit biomedical research organizations. It stands at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Florida, a 364,000 square-foot, state-of-the-art biomedical research facility, will be built in Palm Beach County. The facility will focus on basic biomedical science, drug discovery, and technology development. Palm Beach County and the State of Florida have provided start-up economic packages for development, building, staffing, and equipping the campus. Scripps Florida now operates with approximately 160 scientists, technicians, and administrative staff at 40,000 square-foot lab facilities on the Florida Atlantic University campus in Jupiter.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.